| A Comprehensive Review on Ocimum basilicum B Purushothaman, RP Srinivasan, P Suganthi, B Ranganathan, J Gimbun, ... Journal of Natural Remedies, 71-85, 2018 | 174 | 2018 |
| Lipid peroxidation and anti-obesity activity of Nigella sativa seeds P Srinivasan Ramalingam, MAS Raj, P Ravichandran, K Shanmugam, ... World J. Pharm. Res 6, 882-892, 2017 | 17 | 2017 |
| N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro JR Mekala, RK Kurappalli, PS Ramalingam, NR Moparthi Life sciences 286, 120024, 2021 | 13 | 2021 |
| Distinctive pharmacological activities of Eclipta abla and its coumestan wedelolactone P Balakrishnan, GK Sekar, PS Ramalingam, S Nagarasan, V Murugesan, ... Indo American Journal of Pharmaceutical Sciences 5 (4), 2996-3002, 2018 | 13 | 2018 |
| Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC … JR Mekala, PS Ramalingam, S Mathavan, RBRD Yamajala, NR Moparthi, ... Chemico-biological interactions 357, 109876, 2022 | 11 | 2022 |
| Isolation and characterisation of cellulolytic activity of bacteria and fungi from the soil of paper recycling unit at periyar maniammai university KJ Saranya, P Balakrishnan, PS Ramalingam, S Parthasarathi, ... Indo Ame J Pharma Res 7 (6), 8253-8264, 2017 | 10 | 2017 |
| Identification of dietary bioflavonoids as potential inhibitors against KRAS G12D mutant—novel insights from computer-aided drug discovery PS Ramalingam, P Balakrishnan, S Rajendran, A Jothi, R Ramalingam, ... Current Issues in Molecular Biology 45 (3), 2136-2156, 2023 | 6 | 2023 |
| Potential Biomarkers Uncovered by Bioinformatics Analysis in Sotorasib Resistant-Pancreatic Ductal Adenocarcinoma PS Ramalingam, A Priyadharshini, AE Isaac, S Arumugam Frontiers in Medicine 10, 836, 2023 | 4 | 2023 |
| ROS Modulatory Role of HDAC Inhibitors in Cancer Cells: A Systemic Approach JR Mekala, PS Ramalingam, NR Moparthi, VK Kutala Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 1-28, 2022 | 4 | 2022 |
| Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS PS Ramalingam, S Arumugam Medical Oncology 40 (10), 283, 2023 | 3 | 2023 |
| A green one-pot synthetic protocol of hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one derivatives: molecular docking, ADMET, anticancer and antimicrobial studies HD Trivedi, BY Patel, SD Hadiyal, G Italiya, PS Ramalingam Molecular Diversity 28 (1), 183-195, 2024 | 1 | 2024 |
| Computational design and validation of effective siRNAs to silence oncogenic KRAS PS Ramalingam, S Arumugam 3 Biotech 13 (11), 350, 2023 | 1 | 2023 |
| Synthesis of 8-methyl-2-phenylquinazolin-4 (3H)-ones derived Schiff's bases: spectroscopic properties, SAR, docking approaches and their anticancer and antimicrobial activity N Ramani, BY Patel, G Italiya, PS Ramalingam, R Mishra, S Subramanian, ... Journal of Molecular Structure, 138256, 2024 | | 2024 |
| Liver X receptors (LXRs) in Cancer-An Eagle's View on Molecular Insights and Therapeutic Opportunities PS Ramalingam, S Elangovan, JR Mekala, S Arumugam Frontiers in Cell and Developmental Biology 12, 1386102, 2024 | | 2024 |
| Nigella Sativa L.–A Note on Phytochemistry, Extraction, Pharmacological Activities, and Therapeutic Utility PS Ramalingam, RAK Mishra, JR Mekala, KM Gothandam, S Arumugam Pharmacological Aspects of Essential Oils, 243-264, 2024 | | 2024 |
| Structural insights and functional aspects of phospholipase A2 and phospholipase D in cancer therapy JR Mekala, S Chamarthy, PS Ramalingam, H Angirekula, VK Kutala Phospholipases in Physiology and Pathology, 413-432, 2023 | | 2023 |
| High Glucose modulates the cancer cell fate by regulation of mTOR-HDAC-microRNA axis MJ RAMAIAH, KR Kumar, RP Srinivasan, NR Moparthi, R Reddy, ... | | 2022 |
Dr. Purushothaman Balakrishnan M.T...Scientist and CEOVerified email at pmu.edu
